Elsevier's new generative AI platform, ScienceDirect AI, can rapidly synthesize information on complex topics - say, the popular GLP-1 metabolic drug class. Yet instead of providing a summary derived from potentially untraceable sources, as one might find with a general large language model, ScienceDirect AI grounds its findings directly within its repository of peer-reviewed literature.... The post Can ScienceDirect AI cut literature review time by 50%? Early testing with 30,000+ users shows strong potential appeared first on Research & Development World.